Increased Ca2+ Transient Underlies RyR2-Related Left Ventricular Noncompaction
Mingke Ni,Yanhui Li,Jinhong Wei,Zhenpeng Song,Hui Wang,Jinjing Yao,Yong-Xiang Chen,Darrell Belke,John Paul Estillore,Ruiwu Wang,Alexander Vallmitjana,Raul Benitez,Leif Hove-Madsen,Wei Feng,Ju Chen,Shubhayan Sanatani,Anna Lehman,Thomas M. Roston,S.R. Wayne Chen
DOI: https://doi.org/10.1161/circresaha.123.322504
IF: 23.213
2023-06-17
Circulation Research
Abstract:Circulation Research, Ahead of Print. BACKGROUND:A loss-of-function cardiac ryanodine receptor (RyR2) mutation, I4855M+/–, has recently been linked to a new cardiac disorder termed RyR2 Ca2+release deficiency syndrome (CRDS) as well as left ventricular noncompaction (LVNC). The mechanism by which RyR2 loss-of-function causes CRDS has been extensively studied, but the mechanism underlying RyR2 loss-of-function-associated LVNC is unknown. Here, we determined the impact of a CRDS-LVNC-associated RyR2-I4855M+/–loss-of-function mutation on cardiac structure and function.METHODS:We generated a mouse model expressing the CRDS-LVNC-associated RyR2-I4855M+/–mutation. Histological analysis, echocardiography, ECG recording, and intact heart Ca2+imaging were performed to characterize the structural and functional consequences of the RyR2-I4855M+/–mutation.RESULTS:As in humans, RyR2-I4855M+/–mice displayed LVNC characterized by cardiac hypertrabeculation and noncompaction. RyR2-I4855M+/–mice were highly susceptible to electrical stimulation–induced ventricular arrhythmias but protected from stress-induced ventricular arrhythmias. Unexpectedly, the RyR2-I4855M+/–mutation increased the peak Ca2+transient but did not alter the L-type Ca2+current, suggesting an increase in Ca2+-induced Ca2+release gain. The RyR2-I4855M+/–mutation abolished sarcoplasmic reticulum store overload–induced Ca2+release or Ca2+leak, elevated sarcoplasmic reticulum Ca2+load, prolonged Ca2+transient decay, and elevated end-diastolic Ca2+level upon rapid pacing. Immunoblotting revealed increased level of phosphorylated CaMKII (Ca2+-calmodulin dependent protein kinases II) but unchanged levels of CaMKII, calcineurin, and other Ca2+handling proteins in the RyR2-I4855M+/–mutant compared with wild type.CONCLUSIONS:The RyR2-I4855M+/–mutant mice represent the first RyR2-associated LVNC animal model that recapitulates the CRDS-LVNC overlapping phenotype in humans. The RyR2-I4855M+/–mutation increases the peak Ca2+transient by increasing the Ca2+-induced Ca2+release gain and the end-diastolic Ca2+level by prolonging Ca2+transient decay. Our data suggest that the increased peak-systolic and end-diastolic Ca2+levels may underlie RyR2-associated LVNC.
cardiac & cardiovascular systems,peripheral vascular disease,hematology